A case of acneiform skin eruption associated with ZD1839(Iressa®)

Yong Ju Kim, Kyu Chul Hwang, Dong Soo Yu, Chil Hwan Oh, Hae Jun Song

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Epidermal growth factor (EGF) has an important role in the regulation of the proliferation and differentiation of epidermal keratinocytes, as well as in the survival, angiogenesis and metastasis of various cancer cells. There have been some reports of acneiform skin lesions that occurred in the cancer patients treated with ZD1839(Iressa®), an inhibitor of EGF tyrosine kinase. We report a case of acneiform eruption related to the anticancer drug, ZD1839(Iressa®).

Original languageEnglish
Pages (from-to)478-481
Number of pages4
JournalKorean Journal of Dermatology
Volume42
Issue number4
Publication statusPublished - 2004 Apr

Keywords

  • Acneiform eruption
  • ZD1839

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'A case of acneiform skin eruption associated with ZD1839(Iressa®)'. Together they form a unique fingerprint.

  • Cite this

    Kim, Y. J., Hwang, K. C., Yu, D. S., Oh, C. H., & Song, H. J. (2004). A case of acneiform skin eruption associated with ZD1839(Iressa®). Korean Journal of Dermatology, 42(4), 478-481.